| KATEGORİ | ID | YAZAR | KONU | TARİH |
| BASIC SCIENCE HEPATITIS B | ||||
| IMMUNOLOGY | 1 | H.E.Farrell | From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cellmediated immunity | 1998 |
| 2 | C. Ferrari | Immune Mechanisms of Cellular Injury in viral Hepatitis | 1994 | |
| 3 | B.Rehermann | The Hepatitis B Virus persists for decades after patients recovery from acute viral hapatitis despite active maintenance of a cytotoxic T-lymphocyte response | 1996 | |
| 4 | D.L.Smalley | Autoantibodyise Present in Chronic Hepatitis C and Chronic Hepatitis B Viral Infections | 1998 | |
| 5 | J.A.Waters | A Study of the Antigenicity and Immunogenicity of a New Hepatitis B Vaccine Using a Panel of Monoclonal Antibodyies | 1998 | |
| VIROLOGY | 6 | M.Bruns | Enhancement of Hepatitis B Virus Infection by Noninfectious Subviral Particles | 1998 |
| 7 | A.L.Mason | Molecular Basis for Persistent Hepatitis B Virus Infection In the Liver After Clearance of Serum Hepatitis B Surface Antigen | 1998 | |
| 8 | G.R.Whittaker | Nuclear Import and Export Viruses and Virus Genomes | 1998 | |
| CLINICALSTUDIES | ||||
| ACTIVE VACCINATION | 9 | J.Y.Weissman | Lack of Response to Recombinant Hepatitis B Vaccine in Nonresponders to the Plasma Vaccine | 1988 |
| 10 | Angelico et al | Failure of a Reinforced Triple Course of Hepatitis B Vaccination in Patients Transplanted for HBV-Related Cirrhosis | 2001 | |
| 11 | Barcena et al. | Response to Hepatitis B Virus Vaccine in patients Transplanted for HBV-Related Liver Disease Under Specific Gammaglobulin Prophylaxis | 1999 | |
| 12 | Bienze et al. | Successful Hepatitis B Vaccination in Patients Who Underwent Transplantation for Hepatitis B Virus- Related Cirrhosis: Preliminary Results | 2002 | |
| DIAGNOSIS | 13 | G.L.Davis | Hepatitis B: Diagnosis and Treatment | 1997 |
| 14 | T.Huo | Sero-Clearance of Hepatitis B Surface Antigen in Chronic Carriers Does Not Necessarily Imply a Good Prognosis | 1998 | |
| 15 | C.Juringe | Application of Nested PCR and Mass Spectrometry for DNA - Based Virus Detection HBV-DNA detected in the Majority of Isolated anti-HBc Positive Sera | 1998 | |
| HBV INFECTION IN NEWBORNS | 16 | R.P.Beasley | HBIG Efficacy in the Interruptıon of Perinatal Transmıssıon of Hepatitis B Virus Carrier State | 1981 |
| 17 | R.P.Beasley | Efficacy Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Douple-Blind, Placebo-Controlled Trial | 1983 | |
| 18 | Henrıetta M.H. | Prevention of Hepatitis B Virus Carrier State in Infants Accordıng to Maternal Serum Levels of HBV DNA | 1989 | |
| 19 | C.C.Pao | Prenatal Transmission of Hepatitis B Virus to Neonates Born to Serum Hepatitis B Virus DNA Positive Mothers | 1992 | |
| 20 | V.C.W.Wong | Prevention of the HBsAg Carrier State in Newborn Infants of Mothers Who are Chronic Carriers of HBsAg and HBeAg by Administration of Hepatitis B Vaccine and Hepatitis B Immunglobulin | 1984 | |
| 21 | M.A.Buendia | Hepatitis B Viruses and Cancerogenesis | 1998 | |
| 22 | R.Idilman | Pathogenesis of Hepatitis B and C-induced Hepatocellular Carcinoma | 1998 | |
| 23 | M.W.Lee | Hepatitis B Virus Infection | 1997 | |
| 24 | The Incıdent Investigation Teams and Others | Transmission of Hepatititis B to Patients From Four Infected Surgeons Without Hepatitis B Antigen | 1997 | |
| PHARMACOKINETIC STUDY WITH HEPATECT CP | 25 | W.M.Glöckner | Kinetics of Immunglobulin G Following IV or IM Administration | 1984 |
| 26 | P.A.Thürmann | Pharmacokinetics of viral antibodies after administration of IV immunglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma | 2001 | |
| PROHYXIS OF HBV REINFECTION | 27 | R.A de Man | Long-term application of human polyclonal hepatitis B immunglobulin to prevent hepatic allograft infection | 1993 |
| 28 | Angus et Al. | Combination Low-Dose Hepatitis B Immune Globulin and Lamivudine Therapy Provides Effective Prophylaxis Against Posttransplantation Hepatitis B | 2000 | |
| 29 | Burbach et al. | Intravenous or Intramuscular Anti-HBs Immunglobulin for the Prevention of Hepatitis B Reinfection After Orthotopic Liver Transplantation | 1996 | |
| 30 | Lo et al. | Liver Transplantation in Asian Patients with Chronic Hepatitis B Using Lamivudine Prophylaxis | 2001 | |
| 31 | Mutimer et al. | Lamivudine Without HBIg for Prevention of Graft Reinfection by Hepatitis B: Long Term Follow-up | 2000 | |
| 32 | Nery et al. | Abstract: Lamivudine and Short-term Hepatitis B Immunglobulin (HBIG) for the Prevention of HBV Recurrence after Liver Transplantation | 2001 | |
| 33 | Perilla et al. | Multıcenter Study of Lamivudine Therapy for Hepatitis B After Liver Transplantation | 1999 | |
| 34 | Perilla et al. | A Multicenter United States Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B | 2001 | |
| 35 | Resenau er al. | ESOT: Optimised Individual Dosage for the Prophylaxis of the Hepatitis B Re-infection with Hepatect Supported by Monitoring of Anti-HBs | 2001 | |
| 36 | Sanchez-Fueyo et al. | Hepatitis B Immunglobulin Discontinuation Followed by Hepatitis B Virus Vaccination: A new Strategy in the Prophylaxis of Hepatitis B | 2000 | |
| 37 | Terrault et al. | Abstract: Combined Swhort-Term Hepatitis B Immunglobulin (HBIG) and Long Term Lamivudine (LAM) versus HBIG Monotherapy as Hepatitis B Virus (HBV) Prophylaxis in Liver Transplant Recipients | 1998 | |
| 38 | Yae et al. | Intramuscular Hepatitis B Immun Globulin Combined with Lamivudine for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation. | 1999 | |
| 39 | R.C.Dickson | Managing Post-Transplantation Viral Hepatitis: Hepatitis B | 1997 | |
| 40 | Krüger M | European Hepatitis B Immunglobulin Trials: Prevention of Recurrent Hepatitis B After Liver Transplantation | 2000 | |
| 41 | J.M.Langrehr | Liver Tranplantation in HBsAg+ Patients With Postoperative Immunoprophylaxis | 1997 | |
| 42 | J.S.Markowitz | Prophylaxis Against Hepatitis B Recurrence Following Liver Tranplantation Using Combination Lamivudine and Hepatitis B Immunglobulin | 1998 | |
| 43 | R.W.McGroy | Improved Outcome of Orthotopic Liver Transplantation for Chronic Hepatitis B Cirrhosis With Aggressive Passive Immunization | 1996 | |
| 44 | R.Müller | Liver transplantation in HBs Antigen (HBsAg) Carriers Prevention of Hepatitis B Virus (HBV) Recurrence by Passive Immunization | 1991 | |
| 45 | Partovi | A Study of Pharmacokinetic Profile of Low-Dose Hepatitis B Immunglobulin in Long-Term Liver Transplant Recipients for Choronic Hepatitis B Infection | 2001 | |
| 46 | Pruett TL | Hepatitis B Immunglobulin: the US experience | 2000 | |
| 47 | J.Rosenau | Lamivudine and low - dose hepatitis B immunglobulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection | 2001 | |
| 48 | D.Samuel | Liver Transplantation in European Patients with the Hepatitis B Surface Antigen | 1993 | |
| 49 | D.Samuel | Hepatitis B virus and liver transplantation | 2000 | |
| 50 | D.Shouval | Hepatitis B Immunglobulin Prevent Hepatitis B Virus Graft Reinfection Following Liver Transplantation: A Concise Review | 2000 | |
| 51 | N.A. Terrault | Prophylaxis inLiver Transplant Recipients Using a Fiexd Dosing Schedule of Hepatitis B Immunglobulin | 1996 | |
| VIRAL RESITENCY | 52 | T.T.Aye | Hepatitis B Virus Polymerase Mutations During Aniviral Therapy in a Patient Following Liver Tranplantation | 1997 |
| 53 | C.Trautwein | Hepatitis B Virus Mutations in the Pre-S Genome Before and After Liver Transplantation | 1996 | |
| VIROSTATIC DRUGS | 54 | A.Bartholomeusz | Clinical Experience With Famciclovir Aganist Hepatitis B Virus | 1997 |
| 55 | E.Jaeckel | Experience With Lamivudine Against Hepatitis B Virus | 1997 | |
| 56 | Reusser | Herpes Virus Resistance to antiviral drugs: a review of the mechanisms clinical importance and therapeutic options | 1996 | |